NORGES BANK

Bank

Position in JAZZ — Jazz Pharmaceuticals plc

CIK 1374170 OSLO, Q8

Position in JAZZ

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$158,279,457

+$86,722,699 QoQ

Shares Held

656,843

+16.9% QoQ

Ownership

1.01%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#23

of 640 holders

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. JAZZ ranks #11 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,971,681	$1,476,123,103
2	REGN	Regeneron Pharmaceuticals, Inc.	1,172,808	$731,292,700
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,271,813	$683,883,867
4	BMRN	Biomarin Pharmaceutical Inc	8,207,954	$469,659,127
5	RVMD	Revolution Medicines, Inc.	2,157,479	$404,052,667
6	INSM	INSMED Inc	3,377,641	$360,124,083
7	ARWR	Arrowhead Pharmaceuticals, Inc.	3,896,536	$317,606,649
8	RPRX	Royalty Pharma plc	5,336,084	$299,194,229

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$158,279,457	656,843	+16.9%	Shares	Sole	2026-08-12
2021-12-31	$71,556,758	561,670	+7.8%	Shares	Sole	2022-03-09
2021-09-30	$67,826,128	520,898	-3.8%	Shares	Sole	2022-11-14
2021-06-30	$96,227,410	541,699	-2.4%	Shares	Sole	2022-08-15
2021-03-31	$91,221,405	554,976	-3.3%	Shares	Sole	2022-05-09
2020-12-31	$94,695,456	573,738	-6.3%	Shares	Sole	2021-03-02
2020-09-30	$87,321,973	612,399	-3.8%	Shares	Sole	2021-11-12
2020-06-30	$70,264,953	636,804	-4.8%	Shares	Sole	2021-08-13
2020-03-31	$66,737,530	669,115	—	Shares	Sole	2021-05-07
No filing history on record for this holder in this stock.